Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Global Blood Therapeutics
Pharma
Pfizer to press pause on large M&A deals, CEO says
Pfizer is taking a “breathing period” from large M&A deals, CEO Albert Bourla told investors this week at Goldman Sachs’ Healthcare Conference.
Fraiser Kansteiner
Jun 11, 2024 10:50am
Pfizer eliminates 52 roles in San Francisco area
Jan 29, 2024 9:58am
Pfizer's potential buyout of Seagen could exceed $40B: analyst
Feb 27, 2023 11:05am
The top 10 biopharma M&A deals of 2022
Jan 30, 2023 3:00am
J&J lost to Pfizer in $5.4B GBT bidding war: Bloomberg
Aug 24, 2022 10:15am
How Pfizer became interested in GBT and reached the $5.4B buy
Aug 23, 2022 10:50am
